Your browser doesn't support javascript.
loading
Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinoma.
Gürlevik, Engin; Fleischmann-Mundt, Bettina; Armbrecht, Nina; Longerich, Thomas; Woller, Norman; Kloos, Arnold; Hoffmann, Dirk; Schambach, Axel; Wirth, Thomas C; Manns, Michael P; Zender, Lars; Kubicka, Stefan; Kühnel, Florian.
Affiliation
  • Gürlevik E; Clinic for Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.
Hepatology ; 58(3): 1031-41, 2013 Sep.
Article in En | MEDLINE | ID: mdl-23686746
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Bile Ducts, Intrahepatic / Cholangiocarcinoma / Deoxycytidine / Antimetabolites, Antineoplastic Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Hepatology Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Bile Ducts, Intrahepatic / Cholangiocarcinoma / Deoxycytidine / Antimetabolites, Antineoplastic Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Hepatology Year: 2013 Document type: Article Affiliation country: Country of publication: